• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[儿童身材矮小的共识性诊断。医院质量保证国家组织]

[Consensus 'diagnosis of short stature in children.' National Organization for Quality Assurance in Hospitals].

作者信息

de Muinck Keizer-Schrama S M

机构信息

Sophia Kinderziekenhuis, afd. Kindergeneeskunde/Endocrinologie, Rotterdam.

出版信息

Ned Tijdschr Geneeskd. 1998 Nov 14;142(46):2519-25.

PMID:10028341
Abstract

Each year about 2500 children in the Netherlands are referred to a specialist because of short stature. Aim of the consensus meeting: 'Diagnosis of short stature in childhood' by general practitioners, pediatricians and pediatric endocrinologists was to promote early diagnosis and treatment of aberrant growth but also to prevent unnecessary referral and interventions. For optimal treatment of growth disorders early diagnosis is of the utmost importance. Short stature is best detected by the use of standard deviation scores (SDS) instead of percentile lines. As cut-off point for referral SDS < -1.3 (< P10) was chosen in order to identify risk groups that need further evaluation. Based on international consensus a diagnostic classification of short stature is possible, distinguishing normal variants and (or) idiopathic short stature from primary and secondary growth disorders. Using target length, the growth curve in the SDS diagram, the actual age and puberty signs, the general practitioner can use a flow chart to determine whether there is a growth problem and whether this needs treatment in primary or secondary health care. Measuring skeletal age has no additional value. Attention should also be given to psychosocial problems as the cause or the effect of short stature.

摘要

在荷兰,每年约有2500名儿童因身材矮小被转诊至专科医生处。全科医生、儿科医生和儿科内分泌学家召开的“儿童身材矮小的诊断”共识会议的目的是促进对异常生长的早期诊断和治疗,同时防止不必要的转诊和干预。对于生长障碍的最佳治疗而言,早期诊断至关重要。使用标准差评分(SDS)而非百分位数线能更好地检测身材矮小。为了确定需要进一步评估的风险群体,选择SDS < -1.3(< P10)作为转诊的临界点。基于国际共识,对身材矮小进行诊断分类是可行的,可区分正常变异和(或)特发性身材矮小与原发性和继发性生长障碍。通过使用目标身高、SDS图表中的生长曲线、实际年龄和青春期体征,全科医生可以使用流程图来确定是否存在生长问题以及这是否需要在初级或二级医疗保健中进行治疗。测量骨龄并无额外价值。还应关注作为身材矮小原因或结果的心理社会问题。

相似文献

1
[Consensus 'diagnosis of short stature in children.' National Organization for Quality Assurance in Hospitals].[儿童身材矮小的共识性诊断。医院质量保证国家组织]
Ned Tijdschr Geneeskd. 1998 Nov 14;142(46):2519-25.
2
[Consensus 'Diagnosis of short stature in children'].
Ned Tijdschr Geneeskd. 1999 Jul 24;143(30):1585-6.
3
Growth deceleration patterns in children with constitutional short stature: an aid to diagnosis.体质性身材矮小儿童的生长减速模式:诊断辅助手段
Pediatrics. 1978 Oct;62(4):529-34.
4
Subclassification of small for gestational age children with persistent short stature: growth patterns and response to GH treatment.持续身材矮小的小于胎龄儿的亚分类:生长模式及对生长激素治疗的反应
Horm Res. 2008;69(2):89-98. doi: 10.1159/000111812. Epub 2007 Dec 5.
5
[Guideline for preventive child health care: 'Detection and referral criteria in short stature'].[儿童预防性保健指南:“身材矮小的检测与转诊标准”]
Ned Tijdschr Geneeskd. 2010;154(18):A2366.
6
Child and adolescent growth disorders--an overview.儿童和青少年生长障碍——概述
Aust Fam Physician. 2005 Sep;34(9):731-7.
7
[Constitutional delay of growth and puberty in male].[男性生长和青春期的体质性延迟]
Nihon Rinsho. 1997 Nov;55(11):2952-7.
8
Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.开始生长激素治疗的年龄以及第一年对生长激素的反应性是特发性矮小症身高结局的主要决定因素。
Horm Res. 2007;68(2):53-62. doi: 10.1159/000098707. Epub 2007 Jan 16.
9
Growth hormone therapy and children with idiopathic short stature: a viable option?生长激素治疗与特发性身材矮小儿童:一个可行的选择?
Pediatr Nurs. 1999 Nov-Dec;25(6):662-5.
10
Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.生长激素治疗与青春期对特发性身材矮小和生长激素缺乏症儿童骨骼及身体成分的影响。
Bone. 2005 Nov;37(5):642-50. doi: 10.1016/j.bone.2005.06.012. Epub 2005 Sep 1.

引用本文的文献

1
Deciphering short stature in children.解读儿童身材矮小问题。
Ann Pediatr Endocrinol Metab. 2020 Jun;25(2):69-79. doi: 10.6065/apem.2040064.032. Epub 2020 Jun 30.
2
Rapid early increase in BMI is associated with impaired longitudinal growth in children with cystic fibrosis.体重指数(BMI)快速早期增加与囊性纤维化患儿纵向生长受损有关。
Pediatr Pulmonol. 2019 Aug;54(8):1209-1215. doi: 10.1002/ppul.24343. Epub 2019 Apr 22.
3
Priority target conditions for algorithms for monitoring children's growth: Interdisciplinary consensus.
儿童生长监测算法的优先目标条件:跨学科共识
PLoS One. 2017 Apr 27;12(4):e0176464. doi: 10.1371/journal.pone.0176464. eCollection 2017.
4
Challenges in the Diagnosis and Management of Growth Hormone Deficiency in India.印度生长激素缺乏症诊断与管理中的挑战
Int J Endocrinol. 2016;2016:2967578. doi: 10.1155/2016/2967578. Epub 2016 Oct 27.
5
Quality of referral of short children to the paediatric endocrinologist and impact of a fax communication system.身材矮小儿童转诊至儿科内分泌专家的质量及传真通信系统的影响。
Paediatr Child Health. 2013 Dec;18(10):533-7. doi: 10.1093/pch/18.10.533.
6
Growth monitoring: a survey of current practices of primary care paediatricians in Europe.生长监测:欧洲初级保健儿科医生当前实践情况的调查。
PLoS One. 2013 Aug 5;8(8):e70871. doi: 10.1371/journal.pone.0070871. Print 2013.
7
Screening rules for growth to detect celiac disease: a case-control simulation study.用于检测乳糜泻的生长筛查规则:一项病例对照模拟研究
BMC Pediatr. 2008 Sep 11;8:35. doi: 10.1186/1471-2431-8-35.
8
The diagnostic work up of growth failure in secondary health care; an evaluation of consensus guidelines.二级医疗保健中生长发育迟缓的诊断检查;共识指南评估
BMC Pediatr. 2008 May 13;8:21. doi: 10.1186/1471-2431-8-21.
9
Referral patterns of children with poor growth in primary health care.基层医疗保健中生长发育不良儿童的转诊模式。
BMC Public Health. 2007 May 11;7:77. doi: 10.1186/1471-2458-7-77.
10
Towards evidence based referral criteria for growth monitoring.迈向基于证据的生长监测转诊标准。
Arch Dis Child. 2004 Apr;89(4):336-41. doi: 10.1136/adc.2003.027839.